US Stock MarketDetailed Quotes
SGHT Sight Sciences
- 4.710
- +0.050+1.07%
Close Nov 5 16:00 ET
- 4.710
- 0.0000.00%
Post 16:59 ET
236.95MMarket Cap-4443P/E (TTM)
4.900High4.560Low512.44KVolume4.680Open4.660Pre Close2.43MTurnover1.67%Turnover RatioLossP/E (Static)50.31MShares8.45052wk High2.33P/B144.27MFloat Cap1.70052wk Low--Dividend TTM30.63MShs Float42.570Historical High--Div YieldTTM7.30%Amplitude1.040Historical Low4.746Avg Price1Lot Size
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
Sight Sciences Stock Forum
Single TearCare® Treatment Improved Functional Visual Outcomes as well as Signs and Symptoms of Patients with Dry Eye Disease in Investigator-Initiated Trial
Sight Sciences (Nasdaq: SGHT) announced the publication of a new study in Clinical Ophthalmology, demonstrating the efficacy of TearCaretreatment for dry eye disease (DED). The study, titled 'Impact of TearCare on Reading Speed in Patients with Dry Eye Disease,' revealed significant improvements in various metr...
Sight Sciences Announces the Publication of Twelve-Month Results of the SAHARA RCT Demonstrating Improved Signs and Symptoms of Dry Eye Disease for TearCare Patients Crossed Over from Restasis
Sight Sciences announced the publication of twelve-month results from the SAHARA trial, showing clinically meaningful improvements in dry eye disease for patients who switched from Restasis to the TearCare treatment. Phase 2 of the trial included 163 patients who had used Rest...
NEWS
Sight Sciences Announces the Publication of Large-Scale, Real-World MIGS Study Demonstrating the Comprehensive Aqueous Outflow Restorative Procedure with OMNI® Surgical System Technology is Effective at Lowering Both IOP and IOP Reducing Medications at 2 Years in Patients with Glaucoma
Sight Sciences, Inc. (Nasdaq: SGHT) announces results of a large-scale MIGS study comparing three leading technologies in glaucoma patients. OMNI technology shows significant IOP and...
In the realm of ophthalmology, groundbreaking advancements are not just welcomed; they are necessary. As we navigate through the complexities of eye diseases, companies like Sight Sciences are leading the charge with innovative solutions that promise not only relief but also a renewed hope for millions globally. Rec...
Gapping up
$Apple (AAPL.US)$ stock rose 0.2% ahead of the iPhone maker's latest hardware update in California later in the session, which is expected to see the launch of the iPhone 15.
$Boeing (BA.US)$ stock rose 0.1% after SMBC Aviation Capital, the world's second largest aircraft leasing firm, said it had concluded an order for 25 Boeing 737 MAX aircraft in a deal worth more than $3.7 billion a...
No comment yet